The score is driven primarily by solid financial performance (growth, improving leverage, and strong recent cash flow) and supportive technical momentum (price above major moving averages with positive MACD). Valuation is a notable positive with a low P/E and moderate dividend yield, partially offset by some margin/cash-flow variability and slightly stretched momentum readings.
Positive Factors
Cash generation
Sustained improvement in operating and free cash flow over 2024–2025 indicates stronger cash conversion of earnings and higher internal funding capacity. Durable cash generation supports reinvestment in R&D/registrations, dividend policy, and reduces reliance on external financing during multi-year product cycles.
Balance sheet repair
Material reduction in debt alongside a sharp rise in equity has strengthened the capital base and reduced financial risk. Lower leverage enhances flexibility to fund regulatory approvals, overseas registrations, and M&A, and improves resilience to cyclical agricultural demand and weather-driven revenue swings.
Revenue & profitability trend
Consistent multi-year revenue growth with healthy gross and operating margins reflects a strong product portfolio and market position in crop protection. Sustainable margins and sales growth indicate enduring demand and pricing power in core agrochemical products across domestic and export channels.
Negative Factors
Margin variability
Year-to-year margin swings and limited operating leverage raise questions about pricing resilience and cost control across product lines. Persistent variability can weaken earnings predictability and constrain reinvestment planning, especially as input costs, formulation mix, or competitive pricing shift over agricultural cycles.
Earlier cash volatility & data gaps
Although cash flow strengthened recently, prior volatility and missing 2025 coverage metrics limit confidence in sustainability. Structural seasonality, timing of receivables from distributors, or episodic working-capital swings could reintroduce cash stress, affecting long-term investment and payout consistency.
Regulatory & cyclical exposure
Business is inherently tied to regulatory approvals and agricultural cycles; new registrations or restrictions materially affect addressable markets. Weather-driven planting decisions and pest/disease incidence create durable demand variability risk, constraining long-term revenue visibility and requiring ongoing R&D and compliance spend.
OAT Agrio Co., Ltd. (4979) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥26.11B
Dividend Yield3.82%
Average Volume (3M)32.11K
Price to Earnings (P/E)10.4
Beta (1Y)0.81
Revenue Growth8.02%
EPS Growth42.17%
CountryJP
Employees601
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)38.25
Shares Outstanding11,072,000
10 Day Avg. Volume42,160
30 Day Avg. Volume32,113
Financial Highlights & Ratios
PEG Ratio0.66
Price to Book (P/B)1.16
Price to Sales (P/S)0.68
P/FCF Ratio4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)316
Revenue Forecast (FY)¥17.50B
OAT Agrio Co., Ltd. Business Overview & Revenue Model
Company DescriptionOAT Agrio Co., Ltd. researches, develops, manufactures, and sells agrochemicals and fertilizers in Japan. The company offers plant protection products and biostimulants. It is also involved in the drug discovery, biological evaluation, formulation development, and pesticide registration activities. The company was formerly known as Otsuka Chemical Co., Ltd. and changed its name to OAT Agrio Co., Ltd. in 2014. OAT Agrio Co., Ltd. was founded in 1950 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyOAT Agrio Co., Ltd. generates revenue primarily through the sale of its crop protection products, fertilizers, and agricultural chemicals. The company’s revenue model is based on the direct sale of these products to farmers, agricultural distributors, and retailers. Key revenue streams include product sales, licensing of proprietary technologies, and partnerships with agricultural cooperatives and organizations. Significant partnerships with research institutions also contribute to the development of innovative products, enhancing the company's market position and driving sales. Additionally, OAT Agrio may engage in export activities to expand its market reach, further bolstering its income.
OAT Agrio Co., Ltd. Financial Statement Overview
Summary
Steady multi-year revenue growth with generally healthy profitability and a strong rebound in operating/free cash flow in 2024–2025. Balance sheet strength has improved as debt declined and equity rose, but margins have shown year-to-year variability and earlier cash flow was uneven.
Income Statement
78
Positive
Revenue has grown steadily from 2020 to 2025 (including a strong rebound after the 2020 decline), with 2025 annual revenue up to 31.95B. Profitability is solid: gross profit has expanded alongside sales, and 2024 margins were healthy (gross margin ~48.5%, operating margin ~10.5%, net margin ~7.0%). The key weakness is some profit variability: 2023 showed stronger margins than 2024, and 2025 net income increased but operating profit did not expand meaningfully versus 2024, implying modest margin pressure and less consistent operating leverage.
Balance Sheet
73
Positive
The balance sheet is improving, with debt trending down from 2020–2025 (15.23B to 9.17B) while equity has risen strongly (6.88B to 18.81B), reducing leverage and strengthening the capital base. Asset growth is also steady. A remaining watch item is that leverage was meaningfully higher earlier in the period (e.g., debt-to-equity above 1x in 2020–2022), and 2025 leverage/return ratios are not provided, limiting visibility into the most recent year’s capital efficiency.
Cash Flow
80
Positive
Cash generation strengthened materially in the last two years: operating cash flow rose from 1.79B (2023) to 3.76B (2024) and 4.90B (2025), and free cash flow increased to 3.28B (2024) and 4.51B (2025). Free cash flow has generally tracked earnings well (free cash flow was ~71%–89% of net income in 2020–2024), supporting earnings quality. The main weakness is volatility earlier in the period (notably weak 2022–2023 operating cash flow) and the absence of coverage/quality ratios for 2025, which would help confirm sustainability of the step-up.
Breakdown
TTM
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
31.28B
31.95B
29.77B
28.99B
26.96B
22.66B
Gross Profit
15.36B
15.37B
14.44B
13.95B
12.66B
10.69B
EBITDA
5.30B
5.37B
4.97B
5.67B
5.04B
3.86B
Net Income
2.28B
2.33B
2.08B
2.49B
2.26B
1.46B
Balance Sheet
Total Assets
37.04B
37.31B
34.66B
34.00B
31.01B
28.32B
Cash, Cash Equivalents and Short-Term Investments
5.62B
5.38B
4.94B
4.06B
3.61B
3.65B
Total Debt
11.32B
9.17B
10.97B
12.30B
11.82B
12.13B
Total Liabilities
18.88B
17.35B
17.56B
19.13B
19.06B
19.20B
Stockholders Equity
17.03B
18.81B
15.95B
13.89B
11.03B
8.30B
Cash Flow
Free Cash Flow
0.00
4.51B
3.28B
1.27B
1.01B
3.20B
Operating Cash Flow
0.00
4.90B
3.76B
1.79B
1.42B
3.60B
Investing Cash Flow
0.00
-1.25B
-555.00M
-585.00M
-569.00M
221.00M
Financing Cash Flow
0.00
-3.33B
-2.48B
-1.05B
-1.03B
-3.94B
OAT Agrio Co., Ltd. Technical Analysis
Technical Analysis Sentiment
Positive
Last Price2254.00
Price Trends
50DMA
2201.29
Positive
100DMA
2199.50
Positive
200DMA
2203.59
Positive
Market Momentum
MACD
63.34
Negative
RSI
68.08
Neutral
STOCH
77.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4979, the sentiment is Positive. The current price of 2254 is below the 20-day moving average (MA) of 2261.05, above the 50-day MA of 2201.29, and above the 200-day MA of 2203.59, indicating a bullish trend. The MACD of 63.34 indicates Negative momentum. The RSI at 68.08 is Neutral, neither overbought nor oversold. The STOCH value of 77.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4979.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026